American Electric upgraded at JefferiesAEP was upgraded from Hold to Buy, Jefferies said. Valuation call, even though first quarter earnings missed estimates. $38.50 price target.
Athenahealth downgraded at LeerinkATHN was downgraded from Outperform to Market Perform, Leerink Swann said. Company lost key customers and failed to add new providers. Estimates also lowered.
Baldor Electric downgraded at LongbowBEZ was downgraded from Buy to Neutral, Longbow Research said. Stock is pricing in the company's strong market share and operating leverage.
Commscope upgraded at BairdCTV was upgraded from Neutral to Outperform, Robert Baird said. Company had a strong quarter, given better enterprise spending and wireless CapEx. $39 price target.
Goldman Sachs downgraded at BofA/MerrillGS downgraded to Neutral from Buy on reports that federal prosecutors have opened an investigation of GS in connection with its trading activities, raising the possibility of criminal changes, Bank of America/Merrill Lynch said. $160 price target.
Halliburton downgraded at FBRHAL was downgraded from Outperform to Market Perform, FBR Capital Markets said. $35 price target. Gulf of Mexico tragedy could hang over the stock.
Harman upgraded at BairdHAR was upgraded from Underperform to Neutral, Robert Baird said. Valuation call, based on a $45 price target. Company had a good quarter and guidance could still prove to be conservative.
ITC downgraded at DeutscheITC was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, as the company has few near-term catalysts. $58 price target.
Jarden downgraded at GoldmanJAH was downgraded to Neutral, Goldman Sachs said. Estimates also cut, as the company is facing margin headwinds. $38 price target.
Mead Johnson Nutrition downgraded at Credit SuisseMJN downgraded to Neutral from Outperform on valuation, Credit Suisse said. Estimates lowered through 2012. Maintain $54 price target.
Microstrategy downgraded at FBRMSTR was downgraded from Outperform to Market Perform, FBR Capital Markets said. Expenses are running above expectations. $90 price target.
O'Reilly Automotive downgraded at FBRORLY was downgraded from Outperform to Market Perform, FBR Capital Markets said. Company is facing difficult comps and may struggle to deliver continued earnings upside.
PPL downgraded at UBSPPL was downgraded from Buy to Neutral, UBS said. Estimates also lowered, as the Kentucky utility deal should dilute earnings. $26 price target.
Transocean downgraded at FBRRIG was downgraded from Outperform to Market Perform, FBR Capital Markets said. $87 price target. Deepwater Horizon catastrophe could weigh on the name.
Spirit AeroSystems upgraded at Credit SuisseSPR upgraded to Outperform from Neutral. Upward pressure on BA production rates boosts SPR forecast, Credit Suisse said. Price target lifted to $30.
Thoratec upgraded at BofA/MerrillTHOR upgraded to Buy from Neutral based on the better than expected early launch of Heartmate II highlighted in the company 1Q10 results, Bank of America/Merrill Lynch said. Price target raised to $47.
Thoratec estimates, target boosted at UBSShares of THOR now seen reaching $44, according to UBS. Estimates also upped, as the company can continue to grow sales and margins throughout 2010. Buy rating.
Thoratec upgraded at WellsTHOR was upgraded from Market Perform to Outperform, Wells Fargo said. Estimates also raised, as pipeline visibility is improving.
Trimble Navigation upgraded at DeutscheTRMB was upgraded to Buy, Deutsche Bank said. $36 price target. Company boosted guidance, and is seeing an improving E&C market.
DENTSPLY International initiated at Credit SuisseCredit Suisse initiated coverage on the largest dental consumable manufacturer with a Neurtral rating and $41 price target. XRAY 2010 and 2011 EPS estimates set at $1.94 and $2.12, respectively.
AET price target improved to $38 from $36. Strong earnings and stronger quality, Barclays said. 2010 and 2011 EPs estimates jumped to $2.80 and $2.90, respectively. Overweight rating.
Acme Packet numbers raised at Goldman
Shares of APKT now seen reaching $25, according to Goldman Sachs. Estimates also increased, given improved operating leverage. Neutral rating.
Acme Packet numbers raised at GoldmanShares of APKT now seen reaching $25, according to Goldman Sachs. Estimates also increased, given improved operating leverage. Neutral rating.
Avnet estimates, target upped at UBSAVT estimates were boosted through 2011, UBS said. BELM acquisition is adding to earnings. Buy rating and new $37 price target.
Autozone estimates, target raised at GoldmanShares of AZO now seen reaching $192, according to Goldman Sachs. Estimates also increased, as the industry is showing higher growth. Neutral rating.
BorgWarner estimates, target increased at GoldmanBWA estimates were raised through 2012, Goldman Sachs said. Company is seeing productivity gains and should benefit from the Dytech acquisition. Neutral rating and new $46 price target.
Colgate-Palmolive numbers reduced at GoldmanShares of CL now seen reaching $98, according to Goldman Sachs. Company is seeing a lower currency benefit. Buy rating.
Colgate-Palmolive target, estimates higher at BarclaysCL price target increased to $87 from $84 after the company delivered another classic high-quality earnings report, Barclays said. 2010 and 2011 EPS estimates lifted to $4.83 and $5.38, respectively. Equal Weight rating.
ConocoPhillips target, estimates raised at BarclaysCOP price target lifted to $60 from $55 on 1Q10 EPS beat, Barclays said. 2010 and 2011 EPS estimates increased to $5.95 and $7.35, respectively. Equal Weight rating.
Covance estimates, target lowered at GoldmanCVD estimates were cut through 2012, Goldman Sachs said. Company had a poor quarter and will struggle to recover. Neutral rating and new $54 price target.
CVS Caremark numbers increased at Morgan StanleyCVS estimates were raised through 2012, Morgan Stanley said. Company should gain PBM market share in 2011. Overweight rating and new $42 price target.
City National numbers raised at FBRShares of CYN now seen reaching $56, according to FBR Capital Markets. Estimates also increased, because of improving credit trends and a higher net interest margin. Market Perform rating.
Emergency Medical numbers upped at GoldmanEMS estimates were boosted through 2012, Goldman Sachs said. Favorable refinancing should drive numbers higher. Neutral rating and new $65 price target.
Hartford Financial numbers upped at FBRHIG estimates were boosted through 2011, FBR Capital Markets said. Company is seeing better margins in the mutual fund business. Market Perform rating and new $32 price target.
Health Management price target boosted at BarclaysHMA price target increased to $11 from $9 as the company is well positioned to benefit from health care reform, Barclays said. Reiterate Overweight rating.
Starwood Hotels numbers raised at FBRShares of HOT now seen reaching $53, according to FBR Capital Markets. Company is seeing a strong recovery in demand. Market Perform rating.
International Paper numbers increased at GoldmanIP estimates were raised through 2012, Goldman Sachs said. Company should benefit from rising containerboard, pulp and uncoated freesheet prices. Buy rating and new $35 price target.
International Rectifier numbers upped at GoldmanIRF estimates were boosted through 2012, Goldman Sachs said. Company is seeing continued recovery and has strong margin leverage. Neutral rating and new $22 price target.
KBW estimates, target increased at FBRKBW estimates were raised through 2011, FBR Capital Markets said. Company is seeing higher investment banking activity. Market Perfor rating and new $27 price target.
Kennametal estimates, target raised at GoldmanShares of KMT now seen reaching $32, according to Goldman Sachs. Estimates also increased, as the company is realizing higher margins. Sell rating.
MetLife estimates, target boosted at FBRShares of MET now seen reaching $52, according to FBR Capital Markets. Estimates also upped, given higher investment income. Outperform rating.
McAfee estimates, target reduced at Morgan StanleyShares of MFE now seen reaching $43.50, according to Morgan Stanley. Estimates also lowered, to match the company's new guidance. Overweight rating.
Mohawk Industries numbers raised at UBSShares of MHK now seen reaching $80, according to UBS. Estimates also increased, as the company can see improved operating leverage. Buy rating.
Mead Johnson numbers boosted at GoldmanShares of MJN now seen reaching 2012, according to Goldman Sachs. Estimates also upped, as the company is seeing higher sales growth. Buy rating.
Maxim Integrated numbers boosted at Morgan StanleyShares of MXIM now seen reaching $22, according to Morgan Stanley. Estimates also upped, as the company should be able to quickly address supply constraints. Overweight rating.
OfficeMax estimates, target upped at GoldmanOMX estimates were boosted through 2012, Goldman Sachs said. Company should be able to hold onto recent margin gains. Neutral rating and new $22 price target.
Oshkosh estimates, target boosted at GoldmanShares of OSK now seen reaching $47, according to Goldman Sachs. Estimates also upped, given an improved outlook for military vehicle parts. Neutral rating.
Procter & Gamble numbers cut at GoldmanShares of PG now seen reaching $68, according to Goldman Sachs. Estimates were also lowered, as the company will raise its marketing spending. Neutral rating.
Procter & Gamble target, estimate increased at BarclaysPG price target raised to $70 from $68. 3Q10 results provide evidence that PG's new strategy is effectively repositioning the company, Barclays said. 2011 EPS estimate lifted 5 cents to $4.10. Overweight rating.
Perrigo estimates, target raised at GoldmanShares of PRGO now seen reaching $61, according to Goldman Sachs. Estimates also increased, given higher margin assumptions across the board. Neutral rating.
QLogic estimates, target upped at Morgan StanleyQLGC estimates were boosted through 2012, Morgan Stanley said. Company is seeing higher sales and a lower realized tax rate. Overweight rating and new $23 price target.
Ryland estimates, target lowered at GoldmanShares of RYL now seen reaching $24, according to Goldman Sachs. Estimates also cut, as the company is seeing a slower ramp in new communities. Neutral rating.
Skyworks Solutions target, estimates boosted at BarclaysSWKS price target raised to $19 from $16 as the RF leader delivered another strong quarter, Barclays said. 2010 and 2011 EPS estimates raised to $1.14 and $1.31, respectively. Equal Weight rating.
Time Warner Cable numbers raised at Morgan StanleyShares of TWC now seen reaching $63, according to Morgan Stanley. Estimates also increased, because of accelerating subscriber growth. Equal-weight rating.
Viacom estimates, target boosted at GoldmanShares of VIA.B now seen reaching $43, according to Goldman Sachs. Estimates also upped, given higher advertising and affiliate fees. Buy rating.
Wynn Resorts numbers increased at UBSWYNN estimates were raised through 2011, UBS said. Company is seeing higher margins in Macau. Buy rating and new $109 price target.
ExxonMobil price target lower at BarclaysXOM price target cut to $88 from $92. Solid production, but missed EPS, Barclays said. Overweight rating.
ExxonMobil estimates cut at UBSXOM estimates were reduced through 2011, UBS said. Copany is seeing lower downstream results. Neutral rating and $72 price target.
